McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine & Public Health, Madison, WI 53705, USA.
Department of Dermatology, University of Wisconsin School of Medicine & Public Health, Madison, WI 53705, USA.
Viruses. 2021 Jan 19;13(1):138. doi: 10.3390/v13010138.
Merkel cell polyomavirus (MCPyV) is a human polyomavirus causally linked to the development of Merkel cell carcinoma (MCC), an aggressive malignancy that largely arises within the dermis of the skin. In this study, we recapitulate the histopathology of human MCC tumors in vitro using an organotypic (raft) culture system that is traditionally used to recapitulate the dermal and epidermal equivalents of skin in three dimensions (3D). In the optimal culture condition, MCPyV+ MCC cells were embedded in collagen between the epidermal equivalent comprising human keratinocytes and a dermal equivalent containing fibroblasts, resulting in MCC-like lesions arising within the dermal equivalent. The presence and organization of MCC cells within these dermal lesions were characterized through biomarker analyses. Interestingly, co-culture of MCPyV+ MCC together with keratinocytes specifically within the epidermal equivalent of the raft did not reproduce human MCC morphology, nor were any keratinocytes necessary for MCC-like lesions to develop in the dermal equivalent. This 3D tissue culture system provides a novel in vitro platform for studying the role of MCPyV T antigens in MCC oncogenesis, identifying additional factors involved in this process, and for screening potential MCPyV+ MCC therapeutic strategies.
Merkel 细胞多瘤病毒(MCPyV)是一种与人相关的多瘤病毒,与 Merkel 细胞癌(MCC)的发展有关,MCC 是一种侵袭性恶性肿瘤,主要发生在皮肤的真皮层。在这项研究中,我们使用传统的器官型(筏)培养系统在体外重现人类 MCC 肿瘤的组织病理学,该系统用于在三维(3D)水平重现皮肤的真皮和表皮等效物。在最佳培养条件下,将包含 MCPyV+MCC 细胞的胶原嵌入由人角质形成细胞组成的表皮等效物和包含成纤维细胞的真皮等效物之间,导致在真皮等效物中出现 MCC 样病变。通过生物标志物分析来描述这些真皮病变中 MCC 细胞的存在和组织。有趣的是,MCPyV+MCC 与角质形成细胞在筏的表皮等效物中的共培养并没有复制人类 MCC 的形态,也不需要角质形成细胞使 MCC 样病变在真皮等效物中发展。这种 3D 组织培养系统为研究 MCPyV T 抗原在 MCC 发生中的作用、鉴定该过程中涉及的其他因素以及筛选潜在的 MCPyV+MCC 治疗策略提供了一个新的体外平台。